Richard DeMarco
Impact in
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
- Immunology top 5%
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Immunology 15
- Immune Response and Inflammation 12
- Immunotherapy and Immune Responses 6
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Immune cells in cancer 3
- Immune Cell Function and Interaction 2
-
- RNA Interference and Gene Delivery 3
- Co-authors
- Michael T. Lotze (16 shared papers)Elieser Gorelik (2 shared papers)Adele Marrangoni (2 shared papers)Anna Lokshin (2 shared papers)Vera Levina (2 shared papers)Mitchell P. Fink (3 shared papers)Herbert J. Zeh (4 shared papers)Donna Beer–Stolz (2 shared papers)
- Journals
- The Journal of Immunology (6 papers)Journal of Immunotherapy (3 papers)PLoS ONE (2 papers)Journal of Leukocyte Biology (2 papers)Mutation Research/Genetic Toxicology and Environmental Mutagenesis (1 paper)
- Partner nations
- United StatesChinaCambodia
In The Last Decade
Richard DeMarco
26 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 94
- Clinical Biochemistry 301
- Immunology 500
- Immunology and Allergy 120
- Oncology 405
- Neurology 122
Countries citing papers authored by Richard DeMarco
This map shows the geographic impact of Richard DeMarco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard DeMarco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard DeMarco more than expected).
Fields of papers citing papers by Richard DeMarco
This network shows the impact of papers produced by Richard DeMarco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard DeMarco. The network helps show where Richard DeMarco may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard DeMarco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 346 | |
| 2 | 2009 | 146 | |
| 3 | 2002 | 115 | |
| 4 | 2006 | 102 | |
| 5 | 2007 | 102 | |
| 6 | 2005 | 101 | |
| 7 | 2009 | 90 | |
| 8 | 2000 | 87 | |
| 9 | 2004 | 84 | |
| 10 | 2006 | 72 | |
| 11 | 1996 | 71 | |
| 12 | 2006 | 52 | |
| 13 | 2014 | 43 | |
| 14 | 2008 | 29 | |
| 15 | 2018 | 23 | |
| 16 | 2004 | 21 | |
| 17 | 2008 | 17 | |
| 18 | 2021 | 13 | |
| 19 | Dying dangerously: Necrotic cell death and chronic inflammation promote tumor growth. | 2004 | 11 |
| 20 | 2013 | 8 |
About Richard DeMarco
Richard DeMarco is a scholar working on Immunology, Molecular Biology, Clinical Biochemistry, Cancer Research and Oncology, having authored 26 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immune Response and Inflammation (12 papers), Advanced Glycation End Products research (8 papers), Immunotherapy and Immune Responses (6 papers), RNA Interference and Gene Delivery (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Immune cells in cancer (3 papers), Immune Cell Function and Interaction (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Clinical Biochemistry (301 citations), Immunology (500 citations), Immunology and Allergy (120 citations), Oncology (405 citations) and Neurology (122 citations). Richard DeMarco has collaborated with scholars based in United States, China and Cambodia. Frequent co-authors include Michael T. Lotze, Elieser Gorelik, Adele Marrangoni, Anna Lokshin, Vera Levina, Mitchell P. Fink, Herbert J. Zeh, Donna Beer–Stolz, P. Popovič and David L. Bartlett. Their work appears in journals such as The Journal of Immunology, Journal of Immunotherapy, PLoS ONE, Journal of Leukocyte Biology and Mutation Research/Genetic Toxicology and Environmental Mutagenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.